Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Navigator Technology Ventures (NTV) was a seed-stage venture capital firm based in Cambridge, Massachusetts, dedicated to commercializing breakthrough technologies from research institutions like the Massachusetts Institute of Technology (MIT). Founded in 2002, the firm focused on early-stage opportunities in life sciences, physical sciences, and information technology. NTV provided not only capital but also strategic management and operational support to help transition laboratory innovations into viable commercial enterprises. Its portfolio included several notable healthcare and biotech companies, such as T2 Biosystems and MicroCHIPS. The firm is currently considered inactive and is no longer making new investments. It was particularly known for its 'venture creation' model, often taking an active role in the initial management of its spin-out companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Navigator Technology Ventures.